Two COVID-19 Clinical Trials Seek to Enroll Pregnant Women
From The Scientist comes this exciting new development in clinical research into COVID-19:
“Upon seeing pregnant women sick with COVID-19 at a University of Pennsylvania hospital, researchers there wrote trial protocols for blood transfusions to treat the disease that include expecting mothers.
As a translational infectious disease researcher at the University of Pennsylvania Perelman School of Medicine who had led many clinical trials for experimental HIV therapies, Katharine Bar was acutely aware that pregnant women are rarely included in such research. Then, in the early days of the COVID-19 outbreak in the US, she witnessed several pregnant women suffering from severe symptoms of SARS-CoV-2 infection being admitted to the UPenn hospital system. As she and colleagues put together protocols for two trials to test infusing blood plasma from recovered patients, also called convalescent plasma, into sick patients as a treatment for COVID-19, Bar knew she wanted to include moms-to-be.”
Click the button below to read the article:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?